Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Burns | 87 | 2022 | 1875 | 6.340 |
Why?
|
Neuromuscular Nondepolarizing Agents | 27 | 2011 | 143 | 3.690 |
Why?
|
Neuromuscular Junction | 32 | 2022 | 405 | 3.310 |
Why?
|
Receptors, Cholinergic | 25 | 2015 | 244 | 3.020 |
Why?
|
Muscle, Skeletal | 46 | 2020 | 4947 | 2.650 |
Why?
|
Muscular Atrophy | 12 | 2020 | 334 | 2.580 |
Why?
|
Benzylidene Compounds | 4 | 2021 | 25 | 2.280 |
Why?
|
Tubocurarine | 26 | 2000 | 62 | 1.510 |
Why?
|
Neuromuscular Blocking Agents | 8 | 2022 | 129 | 1.490 |
Why?
|
Muscle Contraction | 28 | 2015 | 1200 | 1.420 |
Why?
|
Receptors, Nicotinic | 13 | 2016 | 494 | 1.380 |
Why?
|
Immobilization | 10 | 2014 | 229 | 1.260 |
Why?
|
Drug Tolerance | 5 | 2019 | 367 | 1.240 |
Why?
|
Critical Illness | 8 | 2022 | 2724 | 1.170 |
Why?
|
Morphine | 4 | 2022 | 656 | 1.100 |
Why?
|
Neuromuscular Depolarizing Agents | 6 | 2009 | 42 | 1.090 |
Why?
|
Muscles | 19 | 2017 | 1568 | 1.090 |
Why?
|
Rats, Sprague-Dawley | 42 | 2022 | 8164 | 1.080 |
Why?
|
Synaptic Transmission | 8 | 2014 | 1167 | 1.080 |
Why?
|
Isoquinolines | 7 | 2011 | 352 | 1.030 |
Why?
|
Pyridines | 4 | 2021 | 2872 | 0.980 |
Why?
|
Androstanols | 5 | 2009 | 45 | 0.950 |
Why?
|
Succinylcholine | 8 | 2013 | 65 | 0.900 |
Why?
|
Neuromuscular Blockade | 6 | 2009 | 147 | 0.890 |
Why?
|
Apoptosis | 13 | 2019 | 9477 | 0.870 |
Why?
|
Electric Stimulation | 11 | 2015 | 1736 | 0.860 |
Why?
|
Carbamazepine | 3 | 2019 | 224 | 0.810 |
Why?
|
Analgesics, Opioid | 6 | 2019 | 3805 | 0.760 |
Why?
|
Rats | 49 | 2022 | 23704 | 0.750 |
Why?
|
Mitochondria | 10 | 2023 | 3620 | 0.750 |
Why?
|
Fentanyl | 2 | 2019 | 433 | 0.730 |
Why?
|
Spinal Cord | 4 | 2022 | 1807 | 0.680 |
Why?
|
Botulinum Toxins | 3 | 2013 | 189 | 0.680 |
Why?
|
Muscle Weakness | 8 | 2016 | 412 | 0.660 |
Why?
|
Nitric Oxide Synthase Type II | 7 | 2017 | 517 | 0.660 |
Why?
|
Hyperalgesia | 4 | 2022 | 526 | 0.640 |
Why?
|
Cholinesterase Inhibitors | 4 | 2013 | 241 | 0.640 |
Why?
|
Myoblasts, Skeletal | 2 | 2017 | 74 | 0.620 |
Why?
|
Muscle Fibers, Skeletal | 4 | 2017 | 543 | 0.610 |
Why?
|
Anticonvulsants | 4 | 2019 | 1910 | 0.600 |
Why?
|
Anesthetics, Intravenous | 2 | 2012 | 394 | 0.600 |
Why?
|
Insulin Resistance | 12 | 2015 | 3952 | 0.600 |
Why?
|
Midazolam | 4 | 2016 | 267 | 0.590 |
Why?
|
Refractory Period, Electrophysiological | 2 | 2016 | 40 | 0.570 |
Why?
|
Muscle Proteins | 4 | 2017 | 1149 | 0.570 |
Why?
|
Muscular Disorders, Atrophic | 2 | 2015 | 24 | 0.560 |
Why?
|
Heat-Shock Proteins | 1 | 2020 | 795 | 0.540 |
Why?
|
Pyridostigmine Bromide | 2 | 2013 | 32 | 0.530 |
Why?
|
Pain Measurement | 5 | 2021 | 3549 | 0.530 |
Why?
|
Lipopolysaccharides | 4 | 2019 | 2199 | 0.510 |
Why?
|
Motor Neurons | 2 | 2019 | 869 | 0.510 |
Why?
|
Animals | 99 | 2022 | 168079 | 0.510 |
Why?
|
Nicotinic Agonists | 2 | 2021 | 265 | 0.510 |
Why?
|
Muscular Dystrophy, Animal | 2 | 2013 | 89 | 0.500 |
Why?
|
Propofol | 2 | 2012 | 602 | 0.490 |
Why?
|
Bungarotoxins | 6 | 2015 | 47 | 0.480 |
Why?
|
Microglia | 2 | 2022 | 1358 | 0.460 |
Why?
|
Anesthesia, Intravenous | 3 | 2012 | 129 | 0.450 |
Why?
|
Pain | 5 | 2022 | 5072 | 0.450 |
Why?
|
Neuromuscular Diseases | 3 | 2013 | 260 | 0.450 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2014 | 137 | 0.440 |
Why?
|
Pancuronium | 7 | 2004 | 44 | 0.440 |
Why?
|
Toxins, Biological | 1 | 2013 | 60 | 0.420 |
Why?
|
Glycogen Synthase Kinase 3 | 2 | 2012 | 412 | 0.410 |
Why?
|
Up-Regulation | 12 | 2016 | 4111 | 0.410 |
Why?
|
Caspase 3 | 2 | 2013 | 730 | 0.400 |
Why?
|
Lipolysis | 2 | 2006 | 210 | 0.390 |
Why?
|
Inflammation Mediators | 1 | 2021 | 1885 | 0.390 |
Why?
|
Atracurium | 7 | 2011 | 51 | 0.390 |
Why?
|
Hyperkalemia | 3 | 2006 | 233 | 0.390 |
Why?
|
Inflammation | 7 | 2019 | 10759 | 0.380 |
Why?
|
Analgesics, Non-Narcotic | 1 | 2014 | 370 | 0.380 |
Why?
|
Dose-Response Relationship, Drug | 22 | 2019 | 10756 | 0.370 |
Why?
|
Acetylcholinesterase | 4 | 2009 | 156 | 0.360 |
Why?
|
Vecuronium Bromide | 3 | 2001 | 33 | 0.360 |
Why?
|
Hypnotics and Sedatives | 4 | 2015 | 1178 | 0.350 |
Why?
|
Insulin | 10 | 2019 | 6588 | 0.350 |
Why?
|
Sepsis | 3 | 2021 | 2585 | 0.340 |
Why?
|
Lysine | 2 | 2012 | 982 | 0.340 |
Why?
|
Intubation, Intratracheal | 3 | 2013 | 1331 | 0.320 |
Why?
|
Mice, Inbred C57BL | 16 | 2019 | 22127 | 0.320 |
Why?
|
Male | 99 | 2021 | 360693 | 0.320 |
Why?
|
Phenytoin | 3 | 2001 | 190 | 0.310 |
Why?
|
Dexmedetomidine | 1 | 2013 | 317 | 0.310 |
Why?
|
Hyperglycemia | 3 | 2008 | 1375 | 0.310 |
Why?
|
Monitoring, Intraoperative | 2 | 2013 | 944 | 0.300 |
Why?
|
Drug Interactions | 9 | 2019 | 1417 | 0.300 |
Why?
|
Autophagy | 3 | 2015 | 1327 | 0.300 |
Why?
|
Down-Regulation | 3 | 2013 | 2916 | 0.290 |
Why?
|
Myocardium | 5 | 2012 | 4746 | 0.290 |
Why?
|
Interleukin-6 | 1 | 2017 | 3210 | 0.280 |
Why?
|
Half-Life | 5 | 2019 | 649 | 0.280 |
Why?
|
Perioperative Care | 1 | 2015 | 1037 | 0.280 |
Why?
|
Receptors, Adrenergic, beta | 2 | 1999 | 242 | 0.280 |
Why?
|
Nitric Oxide Synthase | 4 | 2005 | 908 | 0.270 |
Why?
|
Oligopeptides | 1 | 2011 | 1179 | 0.260 |
Why?
|
Piperidines | 1 | 2014 | 1656 | 0.260 |
Why?
|
Disease Models, Animal | 11 | 2019 | 18220 | 0.260 |
Why?
|
Necrosis | 2 | 2007 | 1610 | 0.250 |
Why?
|
Anesthesia | 8 | 2016 | 1591 | 0.250 |
Why?
|
Contracture | 1 | 2008 | 235 | 0.250 |
Why?
|
Mice | 33 | 2019 | 81326 | 0.250 |
Why?
|
Acetophenones | 2 | 2016 | 52 | 0.240 |
Why?
|
Conotoxins | 2 | 2015 | 20 | 0.240 |
Why?
|
Dihydro-beta-Erythroidine | 2 | 2015 | 4 | 0.240 |
Why?
|
Cyclic AMP | 10 | 1999 | 1462 | 0.230 |
Why?
|
Butyrylcholinesterase | 2 | 2011 | 21 | 0.230 |
Why?
|
Pyrazoles | 1 | 2014 | 2010 | 0.230 |
Why?
|
Cholinesterases | 2 | 2002 | 32 | 0.230 |
Why?
|
Enzyme Inhibitors | 3 | 2012 | 3702 | 0.230 |
Why?
|
Hemodynamics | 5 | 2013 | 4165 | 0.220 |
Why?
|
Muscular Diseases | 4 | 2009 | 552 | 0.220 |
Why?
|
Exercise | 1 | 2020 | 5874 | 0.220 |
Why?
|
Antioxidants | 1 | 2011 | 1667 | 0.220 |
Why?
|
Neck | 1 | 2008 | 734 | 0.210 |
Why?
|
Glucocorticoids | 2 | 2004 | 2159 | 0.210 |
Why?
|
Airway Obstruction | 1 | 2008 | 660 | 0.210 |
Why?
|
Cholinergic Agonists | 1 | 2022 | 75 | 0.210 |
Why?
|
Liver | 5 | 2012 | 7514 | 0.210 |
Why?
|
Cimetidine | 3 | 1989 | 76 | 0.200 |
Why?
|
Receptors, Glucocorticoid | 1 | 2004 | 303 | 0.200 |
Why?
|
Muscle Relaxation | 3 | 2009 | 138 | 0.200 |
Why?
|
Sodium Chloride | 2 | 2015 | 584 | 0.200 |
Why?
|
Adipocytes | 3 | 2006 | 1190 | 0.200 |
Why?
|
Endoplasmic Reticulum | 1 | 2007 | 1125 | 0.190 |
Why?
|
Acetylcholine | 4 | 2013 | 629 | 0.190 |
Why?
|
Random Allocation | 5 | 2016 | 2393 | 0.180 |
Why?
|
Receptor, Insulin | 5 | 2011 | 836 | 0.180 |
Why?
|
Lipid Metabolism | 2 | 2006 | 1893 | 0.180 |
Why?
|
Protein Prenylation | 2 | 2017 | 70 | 0.170 |
Why?
|
In Situ Nick-End Labeling | 5 | 2006 | 613 | 0.170 |
Why?
|
Caspases | 2 | 2000 | 878 | 0.170 |
Why?
|
Immunoblotting | 3 | 2017 | 1644 | 0.170 |
Why?
|
Phosphodiesterase 5 Inhibitors | 2 | 2013 | 103 | 0.170 |
Why?
|
Diaphragm | 5 | 1996 | 351 | 0.170 |
Why?
|
Phosphoproteins | 5 | 2005 | 2444 | 0.160 |
Why?
|
Prednisolone | 1 | 2000 | 324 | 0.160 |
Why?
|
Glucose | 5 | 2012 | 4342 | 0.160 |
Why?
|
Toll-Like Receptor 4 | 1 | 2022 | 577 | 0.160 |
Why?
|
Humans | 84 | 2023 | 761208 | 0.160 |
Why?
|
Nucleotides, Cyclic | 2 | 1990 | 83 | 0.160 |
Why?
|
Enzyme Activation | 5 | 2017 | 3577 | 0.150 |
Why?
|
Membrane Potential, Mitochondrial | 2 | 2016 | 295 | 0.150 |
Why?
|
Second Messenger Systems | 2 | 1996 | 201 | 0.150 |
Why?
|
Neurons | 3 | 2019 | 9428 | 0.150 |
Why?
|
Signal Transduction | 11 | 2019 | 23416 | 0.150 |
Why?
|
Ubiquinone | 1 | 2019 | 183 | 0.140 |
Why?
|
Muscle Denervation | 1 | 1997 | 60 | 0.140 |
Why?
|
Drug Administration Schedule | 4 | 2013 | 4851 | 0.140 |
Why?
|
Macrophages | 1 | 2012 | 5753 | 0.140 |
Why?
|
Neutrophil Infiltration | 1 | 2019 | 390 | 0.140 |
Why?
|
Muscle Fatigue | 2 | 2011 | 95 | 0.140 |
Why?
|
Glycyrrhizic Acid | 1 | 2016 | 11 | 0.140 |
Why?
|
Chromatography, Liquid | 2 | 2019 | 982 | 0.140 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2022 | 4340 | 0.140 |
Why?
|
Muscle Relaxants, Central | 3 | 1992 | 93 | 0.140 |
Why?
|
Pseudomonas aeruginosa | 2 | 2016 | 1272 | 0.140 |
Why?
|
Hindlimb Suspension | 1 | 2016 | 75 | 0.130 |
Why?
|
Phosphorylation | 7 | 2012 | 8300 | 0.130 |
Why?
|
Neostigmine | 1 | 1996 | 68 | 0.130 |
Why?
|
Hindlimb | 6 | 2010 | 513 | 0.130 |
Why?
|
Transcription Factor RelA | 1 | 2017 | 254 | 0.130 |
Why?
|
Sirtuin 1 | 1 | 2017 | 246 | 0.130 |
Why?
|
Microcirculation | 2 | 2013 | 1280 | 0.130 |
Why?
|
Sarcopenia | 1 | 2020 | 370 | 0.120 |
Why?
|
Proto-Oncogene Proteins | 2 | 2005 | 4513 | 0.120 |
Why?
|
Insulin Receptor Substrate Proteins | 6 | 2011 | 557 | 0.120 |
Why?
|
Sodium Channels | 1 | 1997 | 339 | 0.120 |
Why?
|
RNA, Messenger | 8 | 2002 | 12747 | 0.120 |
Why?
|
Time Factors | 16 | 2013 | 39957 | 0.120 |
Why?
|
Burns, Inhalation | 1 | 2015 | 35 | 0.120 |
Why?
|
Burns, Electric | 1 | 2015 | 40 | 0.120 |
Why?
|
Tissue Distribution | 1 | 2019 | 2263 | 0.120 |
Why?
|
Cyclic GMP | 3 | 1990 | 395 | 0.120 |
Why?
|
Nicotinic Antagonists | 2 | 2011 | 94 | 0.120 |
Why?
|
Pain Threshold | 1 | 2019 | 603 | 0.120 |
Why?
|
Area Under Curve | 1 | 2019 | 1636 | 0.120 |
Why?
|
Orosomucoid | 5 | 2005 | 45 | 0.120 |
Why?
|
Cardiac Volume | 3 | 1986 | 197 | 0.120 |
Why?
|
Myography | 2 | 2014 | 111 | 0.120 |
Why?
|
Chromatography, High Pressure Liquid | 4 | 1992 | 1535 | 0.120 |
Why?
|
Crotalid Venoms | 1 | 2014 | 28 | 0.110 |
Why?
|
Adipose Tissue | 1 | 2006 | 3313 | 0.110 |
Why?
|
Models, Animal | 1 | 2020 | 2115 | 0.110 |
Why?
|
NF-kappa B | 1 | 2022 | 2475 | 0.110 |
Why?
|
Injections, Spinal | 1 | 2014 | 317 | 0.110 |
Why?
|
Hyperkinesis | 1 | 2014 | 88 | 0.110 |
Why?
|
Cardiac Output | 7 | 1986 | 831 | 0.110 |
Why?
|
Muscle Fibers, Slow-Twitch | 1 | 2013 | 52 | 0.110 |
Why?
|
Atrophy | 2 | 2014 | 1633 | 0.110 |
Why?
|
Binding, Competitive | 3 | 2009 | 1140 | 0.110 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 619 | 0.110 |
Why?
|
Mass Spectrometry | 2 | 2019 | 2189 | 0.110 |
Why?
|
Muscle Fibers, Fast-Twitch | 1 | 2013 | 71 | 0.110 |
Why?
|
Metabolic Clearance Rate | 3 | 2007 | 362 | 0.110 |
Why?
|
Neuromuscular Agents | 1 | 1995 | 148 | 0.110 |
Why?
|
Carbolines | 2 | 2013 | 295 | 0.110 |
Why?
|
Forkhead Transcription Factors | 1 | 2020 | 1613 | 0.110 |
Why?
|
Physical Stimulation | 1 | 2014 | 517 | 0.110 |
Why?
|
Anesthetics | 3 | 2016 | 523 | 0.110 |
Why?
|
Body Weight | 8 | 2000 | 4618 | 0.110 |
Why?
|
Fibrinogen | 1 | 2016 | 888 | 0.110 |
Why?
|
Neoplasms, Glandular and Epithelial | 1 | 2017 | 487 | 0.100 |
Why?
|
Glycogen Synthase | 1 | 2012 | 62 | 0.100 |
Why?
|
Drug Resistance | 7 | 2005 | 1594 | 0.100 |
Why?
|
Multiple Organ Failure | 2 | 2007 | 386 | 0.100 |
Why?
|
Anesthesia, General | 5 | 2004 | 1174 | 0.100 |
Why?
|
Diazepam | 2 | 1984 | 215 | 0.100 |
Why?
|
Mice, Knockout | 4 | 2017 | 14392 | 0.100 |
Why?
|
Ranitidine | 1 | 1992 | 34 | 0.100 |
Why?
|
Receptors, Progesterone | 1 | 2017 | 1129 | 0.100 |
Why?
|
Glucose Clamp Technique | 1 | 2012 | 262 | 0.100 |
Why?
|
Analysis of Variance | 3 | 2012 | 6223 | 0.100 |
Why?
|
Drug Combinations | 2 | 2016 | 2048 | 0.100 |
Why?
|
Nitriles | 1 | 2017 | 971 | 0.100 |
Why?
|
Blotting, Western | 3 | 2014 | 5032 | 0.100 |
Why?
|
Triazoles | 1 | 2017 | 902 | 0.100 |
Why?
|
Organ Size | 3 | 2001 | 2253 | 0.100 |
Why?
|
Peptides, Cyclic | 1 | 2014 | 392 | 0.100 |
Why?
|
Anesthesia Recovery Period | 2 | 2004 | 155 | 0.100 |
Why?
|
Intensive Care Units | 2 | 2019 | 3744 | 0.090 |
Why?
|
Pseudomonas Infections | 1 | 2016 | 621 | 0.090 |
Why?
|
Toxemia | 1 | 1990 | 14 | 0.090 |
Why?
|
Reactive Oxygen Species | 3 | 2016 | 2138 | 0.090 |
Why?
|
Transcription, Genetic | 2 | 2004 | 7571 | 0.090 |
Why?
|
Aging | 5 | 2014 | 8702 | 0.090 |
Why?
|
Chemokine CCL2 | 1 | 2013 | 602 | 0.090 |
Why?
|
Endotoxins | 2 | 1990 | 520 | 0.090 |
Why?
|
Injections, Intramuscular | 1 | 2011 | 555 | 0.090 |
Why?
|
Isaacs Syndrome | 1 | 2009 | 5 | 0.080 |
Why?
|
Mitochondrial Diseases | 1 | 2013 | 342 | 0.080 |
Why?
|
Phosphatidylinositol 3-Kinases | 7 | 2011 | 2864 | 0.080 |
Why?
|
Neuromuscular Junction Diseases | 1 | 2009 | 14 | 0.080 |
Why?
|
Adolescent | 20 | 2016 | 88298 | 0.080 |
Why?
|
Female | 33 | 2019 | 392544 | 0.080 |
Why?
|
Synaptic Potentials | 1 | 2009 | 44 | 0.080 |
Why?
|
Receptors, Estrogen | 1 | 2017 | 2208 | 0.080 |
Why?
|
Neuroglia | 1 | 2014 | 953 | 0.080 |
Why?
|
Adult | 28 | 2019 | 221119 | 0.080 |
Why?
|
Muscle Strength | 2 | 2010 | 624 | 0.080 |
Why?
|
Child, Preschool | 12 | 2013 | 42224 | 0.080 |
Why?
|
Protein-Energy Malnutrition | 1 | 1989 | 189 | 0.080 |
Why?
|
Antacids | 2 | 1986 | 94 | 0.080 |
Why?
|
Child | 22 | 2016 | 80152 | 0.070 |
Why?
|
Nitric Oxide Donors | 2 | 2005 | 126 | 0.070 |
Why?
|
Hypoglycemic Agents | 1 | 2000 | 3089 | 0.070 |
Why?
|
Pneumonia | 1 | 2019 | 2142 | 0.070 |
Why?
|
Synaptic Vesicles | 1 | 2009 | 190 | 0.070 |
Why?
|
Middle Aged | 24 | 2019 | 220853 | 0.070 |
Why?
|
Cell Line | 3 | 2017 | 15545 | 0.070 |
Why?
|
MyoD Protein | 2 | 2001 | 141 | 0.070 |
Why?
|
Infant | 9 | 2013 | 36169 | 0.070 |
Why?
|
Denervation | 2 | 2015 | 265 | 0.070 |
Why?
|
Pulmonary Wedge Pressure | 2 | 1986 | 275 | 0.070 |
Why?
|
Host-Pathogen Interactions | 1 | 2016 | 1448 | 0.070 |
Why?
|
Rats, Inbred Strains | 4 | 1992 | 2087 | 0.070 |
Why?
|
Infusions, Intravenous | 2 | 2004 | 2217 | 0.070 |
Why?
|
Lorazepam | 1 | 1988 | 155 | 0.070 |
Why?
|
Kinetics | 5 | 1999 | 6312 | 0.070 |
Why?
|
Neutrophils | 1 | 2019 | 3763 | 0.070 |
Why?
|
Palliative Care | 1 | 2002 | 3599 | 0.070 |
Why?
|
Gastric Mucosa | 2 | 1992 | 603 | 0.070 |
Why?
|
Potassium | 3 | 1987 | 1309 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2017 | 2915 | 0.070 |
Why?
|
Oxidative Stress | 2 | 2016 | 3114 | 0.070 |
Why?
|
Ulnar Nerve | 3 | 2000 | 102 | 0.070 |
Why?
|
Adrenergic beta-Agonists | 2 | 1999 | 346 | 0.070 |
Why?
|
Obesity | 1 | 2008 | 12939 | 0.060 |
Why?
|
Nuclear Proteins | 1 | 2020 | 5782 | 0.060 |
Why?
|
Systemic Inflammatory Response Syndrome | 2 | 2008 | 619 | 0.060 |
Why?
|
Cells, Cultured | 4 | 2012 | 18926 | 0.060 |
Why?
|
Prospective Studies | 8 | 2017 | 54435 | 0.060 |
Why?
|
Hypothermia | 1 | 1987 | 188 | 0.060 |
Why?
|
Case-Control Studies | 3 | 2011 | 22174 | 0.060 |
Why?
|
Anti-Anxiety Agents | 3 | 2002 | 397 | 0.060 |
Why?
|
Cardiac Output, Low | 1 | 1986 | 191 | 0.060 |
Why?
|
Electromyography | 2 | 2001 | 1393 | 0.060 |
Why?
|
Penicillamine | 1 | 2005 | 60 | 0.060 |
Why?
|
Protein Subunits | 2 | 2006 | 940 | 0.060 |
Why?
|
Tyrosine | 3 | 2011 | 1422 | 0.060 |
Why?
|
Thorax | 1 | 2008 | 555 | 0.060 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2004 | 103 | 0.060 |
Why?
|
Critical Care | 3 | 2013 | 2696 | 0.060 |
Why?
|
Adrenergic beta-Antagonists | 2 | 1987 | 1241 | 0.060 |
Why?
|
Nitric Oxide | 4 | 2007 | 2136 | 0.060 |
Why?
|
Epididymis | 1 | 2006 | 227 | 0.060 |
Why?
|
Imipramine | 1 | 1984 | 98 | 0.060 |
Why?
|
Thermodilution | 2 | 1981 | 50 | 0.060 |
Why?
|
Cytokines | 1 | 2019 | 7386 | 0.060 |
Why?
|
Serine | 2 | 2005 | 826 | 0.060 |
Why?
|
Muscle Cells | 1 | 2005 | 195 | 0.060 |
Why?
|
Threonine | 1 | 2004 | 270 | 0.060 |
Why?
|
Escherichia coli | 2 | 2007 | 4201 | 0.060 |
Why?
|
Blood Glucose | 2 | 2011 | 6392 | 0.060 |
Why?
|
Hydrogen Peroxide | 2 | 2023 | 731 | 0.060 |
Why?
|
Blotting, Northern | 2 | 1997 | 1545 | 0.060 |
Why?
|
Stroke Volume | 6 | 1986 | 5521 | 0.060 |
Why?
|
Escherichia coli Infections | 1 | 2007 | 518 | 0.050 |
Why?
|
Comet Assay | 1 | 2003 | 75 | 0.050 |
Why?
|
Myasthenia Gravis | 2 | 1999 | 214 | 0.050 |
Why?
|
Fasting | 3 | 2005 | 1603 | 0.050 |
Why?
|
RNA, Small Interfering | 1 | 2012 | 3412 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2004 | 471 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-akt | 3 | 2011 | 2455 | 0.050 |
Why?
|
Cattle | 2 | 2001 | 3818 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2004 | 475 | 0.050 |
Why?
|
Microscopy, Electron | 2 | 2003 | 2561 | 0.050 |
Why?
|
Glycogen Phosphorylase | 1 | 2002 | 15 | 0.050 |
Why?
|
Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2002 | 40 | 0.050 |
Why?
|
Aged | 14 | 2019 | 169288 | 0.050 |
Why?
|
Microscopy | 1 | 2007 | 904 | 0.050 |
Why?
|
Injections, Intravenous | 2 | 2000 | 1376 | 0.050 |
Why?
|
Benzodiazepines | 3 | 2002 | 1134 | 0.050 |
Why?
|
Jurkat Cells | 1 | 2003 | 739 | 0.050 |
Why?
|
Analgesia, Patient-Controlled | 1 | 2002 | 116 | 0.050 |
Why?
|
Anesthetics, Dissociative | 1 | 2002 | 80 | 0.050 |
Why?
|
Agrin | 1 | 2001 | 75 | 0.050 |
Why?
|
Thoracic Surgery | 1 | 2008 | 722 | 0.050 |
Why?
|
Enzyme Induction | 1 | 2002 | 452 | 0.050 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2023 | 392 | 0.050 |
Why?
|
RNA Processing, Post-Transcriptional | 1 | 2004 | 394 | 0.050 |
Why?
|
Action Potentials | 1 | 2009 | 1830 | 0.050 |
Why?
|
Isometric Contraction | 1 | 2001 | 150 | 0.050 |
Why?
|
Guanidines | 1 | 2002 | 194 | 0.050 |
Why?
|
Thumb | 2 | 2000 | 232 | 0.050 |
Why?
|
Ketamine | 1 | 1987 | 517 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2016 | 3803 | 0.050 |
Why?
|
Cytochrome c Group | 1 | 2000 | 122 | 0.050 |
Why?
|
Ventilator Weaning | 1 | 2002 | 164 | 0.050 |
Why?
|
Tissue Expansion | 1 | 2002 | 160 | 0.040 |
Why?
|
Phosphotyrosine | 2 | 2001 | 455 | 0.040 |
Why?
|
Food Deprivation | 1 | 2000 | 114 | 0.040 |
Why?
|
Respiratory Insufficiency | 2 | 2008 | 1232 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2017 | 4872 | 0.040 |
Why?
|
Wasting Syndrome | 1 | 2000 | 96 | 0.040 |
Why?
|
Hydrogen-Ion Concentration | 3 | 1992 | 2477 | 0.040 |
Why?
|
Myocardial Reperfusion Injury | 1 | 2003 | 480 | 0.040 |
Why?
|
Abdominal Muscles | 1 | 2000 | 169 | 0.040 |
Why?
|
Hypocalcemia | 1 | 1981 | 200 | 0.040 |
Why?
|
Sterol Esterase | 1 | 1999 | 39 | 0.040 |
Why?
|
Hepatocytes | 2 | 2023 | 1231 | 0.040 |
Why?
|
Reference Values | 3 | 2001 | 4921 | 0.040 |
Why?
|
Length of Stay | 1 | 2013 | 6417 | 0.040 |
Why?
|
Steroids | 1 | 2004 | 929 | 0.040 |
Why?
|
Ethanolamines | 1 | 1999 | 153 | 0.040 |
Why?
|
Lidocaine | 1 | 2002 | 538 | 0.040 |
Why?
|
Heart Ventricles | 5 | 1996 | 3813 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2017 | 9278 | 0.040 |
Why?
|
Ischemia | 1 | 2007 | 1889 | 0.040 |
Why?
|
Dopamine | 1 | 1986 | 1601 | 0.040 |
Why?
|
Drug Synergism | 3 | 1997 | 1756 | 0.040 |
Why?
|
Terminology as Topic | 1 | 2006 | 1528 | 0.040 |
Why?
|
Ceramides | 1 | 1999 | 200 | 0.040 |
Why?
|
Cytoskeleton | 1 | 2023 | 1169 | 0.040 |
Why?
|
Blood Proteins | 3 | 1992 | 1173 | 0.040 |
Why?
|
Pharmaceutical Preparations | 1 | 1986 | 1086 | 0.040 |
Why?
|
Histocytochemistry | 1 | 1999 | 697 | 0.040 |
Why?
|
Phrenic Nerve | 2 | 1996 | 79 | 0.040 |
Why?
|
Electron Transport Chain Complex Proteins | 1 | 2017 | 38 | 0.040 |
Why?
|
Fluid Therapy | 1 | 1981 | 578 | 0.040 |
Why?
|
DNA, Satellite | 1 | 1997 | 66 | 0.040 |
Why?
|
Membrane Potentials | 1 | 2000 | 1088 | 0.040 |
Why?
|
Nervous System Diseases | 1 | 2008 | 1663 | 0.040 |
Why?
|
Microtubules | 1 | 2023 | 1071 | 0.040 |
Why?
|
Glucose Transporter Type 4 | 1 | 1997 | 240 | 0.040 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 1 | 1999 | 481 | 0.030 |
Why?
|
Saxitoxin | 1 | 1997 | 65 | 0.030 |
Why?
|
Receptor, IGF Type 2 | 1 | 1996 | 35 | 0.030 |
Why?
|
Wound Healing | 2 | 2013 | 2800 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2012 | 10422 | 0.030 |
Why?
|
Evoked Potentials, Motor | 1 | 2000 | 464 | 0.030 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 1997 | 277 | 0.030 |
Why?
|
Regional Blood Flow | 2 | 2013 | 1498 | 0.030 |
Why?
|
Sheep | 2 | 1996 | 1436 | 0.030 |
Why?
|
Iodocyanopindolol | 1 | 1996 | 10 | 0.030 |
Why?
|
Centromere | 1 | 1997 | 212 | 0.030 |
Why?
|
Pindolol | 1 | 1996 | 34 | 0.030 |
Why?
|
Capillary Permeability | 1 | 1979 | 773 | 0.030 |
Why?
|
Monosaccharide Transport Proteins | 1 | 1997 | 436 | 0.030 |
Why?
|
Organoplatinum Compounds | 1 | 2017 | 407 | 0.030 |
Why?
|
Isoproterenol | 1 | 1996 | 396 | 0.030 |
Why?
|
Actins | 1 | 2023 | 2046 | 0.030 |
Why?
|
Tissue Array Analysis | 1 | 2017 | 550 | 0.030 |
Why?
|
Gastric Acidity Determination | 2 | 1985 | 56 | 0.030 |
Why?
|
Gene Expression | 2 | 2001 | 7571 | 0.030 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 1 | 1997 | 433 | 0.030 |
Why?
|
Anesthetics, Local | 1 | 2002 | 998 | 0.030 |
Why?
|
Models, Biological | 3 | 2007 | 9457 | 0.030 |
Why?
|
Drug Evaluation | 2 | 1988 | 641 | 0.030 |
Why?
|
Farnesyltranstransferase | 1 | 2015 | 71 | 0.030 |
Why?
|
Hydrolysis | 1 | 1996 | 652 | 0.030 |
Why?
|
Pentobarbital | 1 | 2015 | 153 | 0.030 |
Why?
|
Myocardial Contraction | 1 | 1980 | 1516 | 0.030 |
Why?
|
Wounds and Injuries | 1 | 2007 | 2493 | 0.030 |
Why?
|
Neural Conduction | 1 | 1996 | 441 | 0.030 |
Why?
|
Alkaline Phosphatase | 1 | 1997 | 859 | 0.030 |
Why?
|
Acetylation | 1 | 2017 | 1050 | 0.030 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2001 | 1624 | 0.030 |
Why?
|
Myogenin | 1 | 1993 | 54 | 0.030 |
Why?
|
Mice, Inbred Strains | 2 | 2005 | 1762 | 0.030 |
Why?
|
Tetrazolium Salts | 1 | 2013 | 92 | 0.030 |
Why?
|
Receptor, IGF Type 1 | 1 | 1996 | 380 | 0.030 |
Why?
|
DNA | 2 | 2013 | 7189 | 0.030 |
Why?
|
Respiration, Artificial | 2 | 2002 | 2631 | 0.030 |
Why?
|
Gene Deletion | 1 | 2001 | 2658 | 0.030 |
Why?
|
Transforming Growth Factor beta | 1 | 2001 | 1963 | 0.030 |
Why?
|
Mice, Transgenic | 3 | 2015 | 9520 | 0.030 |
Why?
|
Thiopental | 2 | 1983 | 55 | 0.030 |
Why?
|
Radioligand Assay | 1 | 1993 | 366 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2017 | 790 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2003 | 5871 | 0.030 |
Why?
|
Survival | 1 | 2013 | 161 | 0.030 |
Why?
|
Protein Kinases | 1 | 1999 | 1607 | 0.030 |
Why?
|
Methionine | 1 | 2015 | 570 | 0.030 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 1996 | 790 | 0.030 |
Why?
|
Quorum Sensing | 1 | 2013 | 136 | 0.030 |
Why?
|
Protein Multimerization | 1 | 2017 | 974 | 0.020 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2002 | 2270 | 0.020 |
Why?
|
Protein Binding | 5 | 2001 | 9297 | 0.020 |
Why?
|
Paralysis | 1 | 1993 | 250 | 0.020 |
Why?
|
Immunohistochemistry | 2 | 2017 | 11067 | 0.020 |
Why?
|
Depression, Chemical | 2 | 2002 | 184 | 0.020 |
Why?
|
Infusion Pumps, Implantable | 1 | 1992 | 158 | 0.020 |
Why?
|
Respiration | 2 | 1993 | 1656 | 0.020 |
Why?
|
Body Surface Area | 1 | 1991 | 197 | 0.020 |
Why?
|
Skin Transplantation | 1 | 2016 | 1091 | 0.020 |
Why?
|
Amyloid beta-Protein Precursor | 1 | 1996 | 1111 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2013 | 748 | 0.020 |
Why?
|
Glucuronates | 1 | 1990 | 40 | 0.020 |
Why?
|
Cardiomyopathies | 1 | 2003 | 2021 | 0.020 |
Why?
|
Acute Kidney Injury | 1 | 2003 | 1923 | 0.020 |
Why?
|
Infusions, Subcutaneous | 1 | 2010 | 43 | 0.020 |
Why?
|
Animals, Newborn | 1 | 1996 | 2665 | 0.020 |
Why?
|
Glucuronic Acid | 1 | 1990 | 150 | 0.020 |
Why?
|
Peritoneal Dialysis | 1 | 1991 | 159 | 0.020 |
Why?
|
Transcriptional Activation | 1 | 1996 | 1749 | 0.020 |
Why?
|
Deuterium | 1 | 1990 | 106 | 0.020 |
Why?
|
Membranes | 2 | 2003 | 164 | 0.020 |
Why?
|
Microtubule-Associated Proteins | 1 | 2015 | 1075 | 0.020 |
Why?
|
Muscle Strength Dynamometer | 1 | 2009 | 41 | 0.020 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2013 | 3770 | 0.020 |
Why?
|
Antidepressive Agents | 1 | 2002 | 2893 | 0.020 |
Why?
|
Blood Pressure | 6 | 1986 | 8479 | 0.020 |
Why?
|
Cell Membrane | 2 | 1996 | 3661 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 1999 | 6067 | 0.020 |
Why?
|
Eating | 1 | 1996 | 1535 | 0.020 |
Why?
|
Protein Kinase C | 1 | 2014 | 1202 | 0.020 |
Why?
|
Awards and Prizes | 1 | 1993 | 362 | 0.020 |
Why?
|
Nerve Block | 1 | 2016 | 706 | 0.020 |
Why?
|
Infusion Pumps | 1 | 2010 | 163 | 0.020 |
Why?
|
Genes, Reporter | 1 | 2013 | 1518 | 0.020 |
Why?
|
Antineoplastic Agents, Hormonal | 1 | 2017 | 1520 | 0.020 |
Why?
|
Injections, Intraperitoneal | 1 | 1989 | 413 | 0.020 |
Why?
|
Gastric Acid | 1 | 1989 | 99 | 0.020 |
Why?
|
Linear Models | 1 | 1999 | 5869 | 0.020 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2014 | 894 | 0.020 |
Why?
|
Gene Expression Regulation | 3 | 2016 | 11856 | 0.020 |
Why?
|
Syndrome | 1 | 1995 | 3271 | 0.020 |
Why?
|
Antipsychotic Agents | 1 | 2002 | 3064 | 0.020 |
Why?
|
Glucose Tolerance Test | 1 | 2011 | 1178 | 0.020 |
Why?
|
Biotransformation | 1 | 1988 | 166 | 0.020 |
Why?
|
Insulin-Like Growth Factor I | 1 | 1996 | 1933 | 0.020 |
Why?
|
Calcium | 1 | 1981 | 5719 | 0.020 |
Why?
|
Oxygen | 1 | 1979 | 4227 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 1997 | 6504 | 0.020 |
Why?
|
Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2007 | 32 | 0.020 |
Why?
|
Sciatic Nerve | 1 | 1991 | 618 | 0.020 |
Why?
|
Survival Rate | 1 | 2001 | 12728 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2013 | 1988 | 0.020 |
Why?
|
Theophylline | 1 | 1987 | 131 | 0.020 |
Why?
|
RNA | 1 | 1997 | 2709 | 0.020 |
Why?
|
Young Adult | 2 | 2016 | 59221 | 0.020 |
Why?
|
Pulmonary Circulation | 2 | 1980 | 737 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2013 | 1967 | 0.020 |
Why?
|
Dinoprostone | 1 | 1989 | 597 | 0.020 |
Why?
|
Azathioprine | 1 | 1988 | 354 | 0.020 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2007 | 213 | 0.020 |
Why?
|
Acute-Phase Proteins | 1 | 2007 | 250 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 1993 | 1301 | 0.020 |
Why?
|
Adrenergic Agonists | 1 | 1986 | 57 | 0.020 |
Why?
|
Heart Atria | 2 | 1990 | 1349 | 0.020 |
Why?
|
Thiazoles | 1 | 2013 | 1517 | 0.020 |
Why?
|
Propionibacterium acnes | 1 | 2005 | 59 | 0.020 |
Why?
|
Infusions, Parenteral | 1 | 1986 | 398 | 0.020 |
Why?
|
Pain, Postoperative | 1 | 2016 | 1741 | 0.020 |
Why?
|
Analgesics | 2 | 1997 | 1068 | 0.020 |
Why?
|
Dogs | 2 | 1987 | 3832 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2017 | 58952 | 0.020 |
Why?
|
Guaiac | 1 | 1985 | 13 | 0.020 |
Why?
|
Autoradiography | 2 | 1996 | 729 | 0.020 |
Why?
|
Evoked Potentials | 1 | 1991 | 1047 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 1990 | 1078 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2001 | 7851 | 0.010 |
Why?
|
Tachycardia | 1 | 1987 | 599 | 0.010 |
Why?
|
Hot Temperature | 1 | 1991 | 1434 | 0.010 |
Why?
|
Mice, Obese | 1 | 2005 | 418 | 0.010 |
Why?
|
Epilepsy | 1 | 2000 | 3304 | 0.010 |
Why?
|
Metabolomics | 1 | 2013 | 1658 | 0.010 |
Why?
|
Connective Tissue | 2 | 1996 | 419 | 0.010 |
Why?
|
Vascular Resistance | 3 | 1983 | 933 | 0.010 |
Why?
|
Nordazepam | 1 | 1983 | 5 | 0.010 |
Why?
|
Diastole | 1 | 1986 | 782 | 0.010 |
Why?
|
Nitrogen | 1 | 2005 | 345 | 0.010 |
Why?
|
Blood Flow Velocity | 1 | 2007 | 1375 | 0.010 |
Why?
|
3T3 Cells | 1 | 2005 | 1083 | 0.010 |
Why?
|
Creatinine | 1 | 1989 | 1897 | 0.010 |
Why?
|
COS Cells | 1 | 2005 | 1129 | 0.010 |
Why?
|
Ultrasonography | 1 | 2016 | 5969 | 0.010 |
Why?
|
Catheterization, Central Venous | 1 | 2007 | 526 | 0.010 |
Why?
|
Anxiety | 1 | 1997 | 4569 | 0.010 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2005 | 614 | 0.010 |
Why?
|
Disability Evaluation | 1 | 2009 | 1834 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5300 | 0.010 |
Why?
|
Calcium Metabolism Disorders | 1 | 1981 | 11 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2005 | 1989 | 0.010 |
Why?
|
Societies, Medical | 1 | 1993 | 3923 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2005 | 12159 | 0.010 |
Why?
|
Lung | 1 | 1979 | 9979 | 0.010 |
Why?
|
Serum Albumin | 1 | 1984 | 674 | 0.010 |
Why?
|
Bacteremia | 1 | 2007 | 978 | 0.010 |
Why?
|
Age Factors | 1 | 1997 | 18384 | 0.010 |
Why?
|
Embryonic and Fetal Development | 1 | 2001 | 420 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 2000 | 237 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 1997 | 7400 | 0.010 |
Why?
|
Phosphorus | 1 | 1981 | 332 | 0.010 |
Why?
|
Myostatin | 1 | 2001 | 129 | 0.010 |
Why?
|
Cysteine | 1 | 2005 | 888 | 0.010 |
Why?
|
Ubiquitin | 1 | 2005 | 839 | 0.010 |
Why?
|
Partial Pressure | 1 | 1979 | 245 | 0.010 |
Why?
|
Heart Rate | 3 | 1986 | 4197 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2017 | 9566 | 0.010 |
Why?
|
Oxidation-Reduction | 1 | 2005 | 2227 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2007 | 1901 | 0.010 |
Why?
|
Body Water | 1 | 1980 | 340 | 0.010 |
Why?
|
Rabbits | 2 | 2000 | 4750 | 0.010 |
Why?
|
Vasopressins | 1 | 1980 | 351 | 0.010 |
Why?
|
Oxygen Consumption | 2 | 1988 | 1867 | 0.010 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2005 | 1116 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2005 | 1318 | 0.010 |
Why?
|
Erythrocytes | 1 | 2007 | 2413 | 0.010 |
Why?
|
Skin | 1 | 1991 | 4473 | 0.010 |
Why?
|
Magnesium | 1 | 1981 | 804 | 0.010 |
Why?
|
Chromosomes, Artificial, Yeast | 1 | 1997 | 113 | 0.010 |
Why?
|
Fatty Acids | 1 | 2005 | 1807 | 0.010 |
Why?
|
Hybrid Cells | 1 | 1997 | 421 | 0.010 |
Why?
|
Binding Sites, Antibody | 1 | 1997 | 338 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3777 | 0.010 |
Why?
|
Transfection | 1 | 2005 | 5748 | 0.010 |
Why?
|
Weight Loss | 1 | 2007 | 2680 | 0.010 |
Why?
|
Quality of Life | 1 | 2017 | 13367 | 0.010 |
Why?
|
Biological Availability | 1 | 1996 | 389 | 0.010 |
Why?
|
Veins | 1 | 1979 | 767 | 0.010 |
Why?
|
Alzheimer Disease | 1 | 1996 | 8603 | 0.010 |
Why?
|
Arteries | 1 | 1979 | 1121 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 4567 | 0.010 |
Why?
|
Fetus | 1 | 2001 | 1864 | 0.010 |
Why?
|
Catheterization | 1 | 1978 | 1428 | 0.010 |
Why?
|
Chronic Disease | 1 | 2007 | 9319 | 0.010 |
Why?
|
Iodine Radioisotopes | 1 | 1996 | 1030 | 0.010 |
Why?
|
Gestational Age | 1 | 2001 | 3580 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1996 | 1900 | 0.010 |
Why?
|
Cell Nucleus | 1 | 2000 | 2881 | 0.010 |
Why?
|
Tendons | 1 | 1996 | 558 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1997 | 2509 | 0.010 |
Why?
|
Genetic Markers | 1 | 1997 | 2599 | 0.010 |
Why?
|
Point Mutation | 1 | 1996 | 1593 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2005 | 9416 | 0.010 |
Why?
|
Pulmonary Artery | 1 | 1978 | 1929 | 0.010 |
Why?
|
Acute Disease | 1 | 1980 | 7226 | 0.010 |
Why?
|
Hypertension, Pulmonary | 1 | 1980 | 1592 | 0.000 |
Why?
|
Cell Line, Tumor | 1 | 2005 | 16952 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 1986 | 7407 | 0.000 |
Why?
|
Neuronal Plasticity | 1 | 1996 | 1432 | 0.000 |
Why?
|
Recombinant Fusion Proteins | 1 | 1996 | 3726 | 0.000 |
Why?
|
Kidney | 1 | 2003 | 7033 | 0.000 |
Why?
|
Guideline Adherence | 1 | 1997 | 2220 | 0.000 |
Why?
|
Metoprolol | 1 | 1987 | 90 | 0.000 |
Why?
|
Hypertension | 1 | 1987 | 8536 | 0.000 |
Why?
|
Propanolamines | 1 | 1987 | 163 | 0.000 |
Why?
|
Phenylephrine | 1 | 1987 | 294 | 0.000 |
Why?
|
Enflurane | 1 | 1986 | 16 | 0.000 |
Why?
|
Memory | 1 | 1996 | 2190 | 0.000 |
Why?
|
Halothane | 1 | 1986 | 200 | 0.000 |
Why?
|
United States | 1 | 1993 | 72339 | 0.000 |
Why?
|
Propranolol | 1 | 1987 | 490 | 0.000 |
Why?
|
Nitrous Oxide | 1 | 1986 | 166 | 0.000 |
Why?
|
Base Sequence | 1 | 1996 | 12404 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1996 | 13402 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1996 | 17598 | 0.000 |
Why?
|
Phenotype | 1 | 2001 | 16575 | 0.000 |
Why?
|
Risk Factors | 1 | 2009 | 74239 | 0.000 |
Why?
|
Mutation | 1 | 2005 | 30002 | 0.000 |
Why?
|
Osmolar Concentration | 1 | 1980 | 659 | 0.000 |
Why?
|
Pressure | 1 | 1982 | 1155 | 0.000 |
Why?
|
Surgery, Plastic | 1 | 1984 | 640 | 0.000 |
Why?
|
Retrospective Studies | 1 | 1985 | 80674 | 0.000 |
Why?
|
Sodium | 1 | 1980 | 1589 | 0.000 |
Why?
|
Electrocardiography | 1 | 1986 | 6387 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1982 | 12341 | 0.000 |
Why?
|